The natural history of ulcerative colitis in a pediatric population: A follow-up population-based cohort study

Clinical and Experimental Gastroenterology

Volumn 6, Issue 1, 2013, Pages 77-83

  Mataly, Hoda M ^a   Abraham, Bincy P ^a   Mehta, Seema ^a   Garnett, Elizabeth A ^b   Ferry, George D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Children; Inflammatory bowel disease; Natural history; Ulcerative colitis

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; METRONIDAZOLE; PREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE; STEROID;

ADOLESCENT; AGE; APHTHOUS STOMATITIS; ARTHRITIS; ARTICLE; BODY MASS; CHILD; CHILD HEALTH; COHORT ANALYSIS; COLON RESECTION; FEMALE; FOLLOW UP; GENDER; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE ENDOSCOPY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PATHOLOGICAL ANATOMY; PROCTITIS; RACE; RADIODIAGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SCLEROSING CHOLANGITIS; ULCERATIVE COLITIS;

EID: 84879183064     PISSN: None     EISSN: 11787023     Source Type: Journal    
DOI: 10.2147/CEG.S40259     Document Type: Article

References (37)

1. Malaty HM, Fan X, Opekun AR, Thibodeaux C, Ferry GD. Rising incidence of inflammatory bowel disease among children: a 12-year study. J Pediatr Gastroenterol. 2010;50:27-31.
2. Kugathasan S, Judd RH, Hoffmann RG, et al; Wisconsin Pediatric Inflammatory Bowel Disease Alliance. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003;143:525-531.
3. Russell MG. Changes in the incidence of inflammatory bowel disease: what does it mean? Eur J Intern Med. 2000;11:191-196.
4. Sawczenko A, Sandhu BK, Logan R F, et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet. 2001;357:1093-1094.
5. Logan RF. Inflammatory bowel disease incidence: up, down or unchanged? Gut. 1998;42:309-311.
6. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental infuences. Gastroenterolog y. 2004;6:1504-1517.
7. Turunen P, Kolho KL, Auvinen A, Iltanen S, Huhtala H, Ashorn M. Incidence of inflammatory bowel disease in Finnish children, 1987-2003. Inflamm Bowel Dis. 2006;12:677-683.
8. Lindberg E, Lindquist B, Holmquist L, Hildebrand H. Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995. J Pediatr Gastroenterol Nutr. 2000;30:259-264.
9. Abraham B, Mehta S, El-Serag HB. Natural history of pediatric onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol. 2012;46:581-589.
10. Baumgart DC. The diagnosis and treatment of Crohn's disease and ulcerative colitis. Dtsch Arztebl Int. 2009;106:123-133.
11. Ferry GD, Kirschner BS, Grand RJ, et al. Olsalazine versus sulfasalazine in mild to moderate childhood ulcerative colitis: results of the Pediatric Gastroenterology Collaborative Research Group Clinical Trial. J Pediatr Gastroenterol Nutr. 1993;17:32-38.
12. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369: 1641-1657.
13. Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011;17:423-439.
14. Gower-Rousseau C, Dauchet L, Vernier-Massouille G, et al. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 2009;104:2080-2088.
15. Leshinsky-Silver E, Karban A, Buzhakor E, et al. Is age of onset of Crohn's disease governed by mutations in NOD2/caspase recruitment domains 15 and toll-like receptor 4? Evaluation of a pediatric cohort. Pediatr Res. 2005;58:499-504.
16. Babusukumar U, Wang T, McGuire E, Broeckel U, Kugathasan S. Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. Am J Gastroenterol. 2006;101:1354-1361.
17. Griffths AM. Specifcities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol. 2004;18:509-523.
18. Bousvaros A, Sylvester F, Kugathasan S, et al; Challenges in Pediatric IBD Study Groups. Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:885-913.
19. The City of Houston. Planning and Development. Demographic Data. Available from: http://www.houstontx.gov/planning/Demographics/demog_links.html. Accessed April 30, 2013.
20. The City of Houston. Demographic Data. Available from: http://www. houstontx.gov/planning/Demographics/demog_descriptions.html. Accessed April 30, 2013.
21. Kim SC, Ferry GD. Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations. Gastroenterolog y. 2004;126:1550-1560.
22. Hyams J, Markowitz J, Otley A, et al; Pediatric Inflammatory Bowel Disease Collaborative Research Group. Evaluation of the pediatric Crohn's disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr. 2005;41:416-421.
23. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5-36.
24. Jose FA, Garnett EA, Vittinghoff E, et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:63-68.
25. Eidelwein A P, Thompson R, Fiorino K, Abadon V, Oliva-Hemker M. Disease presentation and clinical course in black and white children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007;44: 555-560.
26. White JM, O'Connor S, Winter HS, et al. Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry. Clin Gastroenterol Hepatol. 2008;6: 1361-1369.
27. Heyman MB. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009;48:243-245.
28. Vestergaard P. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease. Minerva Med. 2004;95: 469-480.
29. Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut. 1987;28:410-415.
30. Heyman MB, Kirschner BS, Gold BD, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of Pediatric IBD Consortium Registry. J Pediatr. 2005;146:35-40.
31. Mendeloff AI, Calkins B. The epidemiology of inflammatory bowel disease. In: Kirsner JB, Shorter RG, editors. Inflammatory Bowel Disease. Philadelphia, PA: Lea and Febiger; 1988;3-34.
32. Hyams JS, Davis P, Grancher K, Lerer T, Justinich CJ, Markowitz J. Clinical outcome of ulcerative colitis in children. J Pediatr. 1996;29: 81-88.
33. Barton JR, Ferguson A. Clinical features, morbidity and mortality of Scottish children with inflammatory bowel disease. Q J Med. 1990;75: 423-439.
34. Van Limbergen J, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008;135:1114-1122.
35. Ferguson A, Sedgwick DM. Juvenile onset inflammatory bowel disease: height and body mass index in adult life. BMJ. 1994;308: 1259-1263.
36. Ferguson A, Sedgwick DM. Juvenile-onset inflammatory bowel disease: predictors of morbidity and health status in early adult life. J R Coll Physicians Lond. 1994;28:220-227.
37. Turunen P, Ashorn M, Auvinen A, Iltanen S, Huhtala H, Kolho KL. Long-term health outcomes in pediatric inflammatory bowel disease: a population-based study. Inflamm Bowel Dis. 2009;15:56-62.